Skip to content

Mativ

US · MATV #3563 by market cap
11.60 -0.26 -2.19%
Live - 5344 symbols - heartbeat 42s ago · 2026-10-09 19:30

Valuation each multiple against its own 5-year range

P/B ratio 1.40 Expensive vs history 87th percentile
5-year average 1.04 · #19 of 56 in Specialty Chemicals
P/E ratio 7.27 Expensive vs history 70th percentile
5-year average -0.92 · forward -223.01 · #2 of 32 in Specialty Chemicals
P/S ratio 0.33 In line with history 36th percentile
5-year average 0.42 · forward 0.32 · #4 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Mativ (MATV) 640.21M 7.07 1.36 3.45%
Linde (LIN) 222.99B 31.21 5.71 1.28%
Ecolab (ECL) 79.01B 37.83 7.86 1.01%
Sherwin-Williams (SHW) 77.53B 29.46 20.11 1.00%
Air Products & Chemicals (APD) 62.63B -1,339.33 4.51 2.56%
PPG Industries (PPG) 23.11B 14.87 2.74 2.73%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value17.50 Economic moatNone UncertaintyHigh

Trading 50.8% below Morningstar's fair value estimate.

Fair value

Mativ Holdings Inc is assigned a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 32% discount to our quantitative fair value estimate of $17.50 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's valuation metrics bolster our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 71.8% lies in the top 45% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 304.7%, a core component of profitability, falls in the top 20% globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-09 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Mativ discussion 0 comments

Add a comment